- Home
- GUTS vs CFSB Comparison
GUTS vs CFSB Comparison
Compare GUTS & CFSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GUTS
- CFSB
- Stock Information
- Founded
- GUTS 2010
- CFSB 1889
- Country
- GUTS United States
- CFSB United States
- Employees
- GUTS N/A
- CFSB N/A
- Industry
- GUTS
- CFSB Major Banks
- Sector
- GUTS
- CFSB Finance
- Exchange
- GUTS NYSE
- CFSB Nasdaq
- Market Cap
- GUTS 54.8M
- CFSB 50.1M
- IPO Year
- GUTS 2024
- CFSB N/A
- Fundamental
- Price
- GUTS $1.33
- CFSB $7.85
- Analyst Decision
- GUTS Buy
- CFSB
- Analyst Count
- GUTS 1
- CFSB 0
- Target Price
- GUTS $10.00
- CFSB N/A
- AVG Volume (30 Days)
- GUTS 292.5K
- CFSB 1.2K
- Earning Date
- GUTS 05-12-2025
- CFSB 05-02-2025
- Dividend Yield
- GUTS N/A
- CFSB N/A
- EPS Growth
- GUTS N/A
- CFSB N/A
- EPS
- GUTS N/A
- CFSB N/A
- Revenue
- GUTS $93,000.00
- CFSB $7,462,000.00
- Revenue This Year
- GUTS N/A
- CFSB N/A
- Revenue Next Year
- GUTS N/A
- CFSB N/A
- P/E Ratio
- GUTS N/A
- CFSB N/A
- Revenue Growth
- GUTS N/A
- CFSB N/A
- 52 Week Low
- GUTS $0.87
- CFSB $6.34
- 52 Week High
- GUTS $7.89
- CFSB $8.28
- Technical
- Relative Strength Index (RSI)
- GUTS 56.78
- CFSB 54.12
- Support Level
- GUTS $0.87
- CFSB $7.73
- Resistance Level
- GUTS $1.39
- CFSB $7.98
- Average True Range (ATR)
- GUTS 0.12
- CFSB 0.16
- MACD
- GUTS 0.05
- CFSB 0.02
- Stochastic Oscillator
- GUTS 88.39
- CFSB 81.94
About GUTS FRACTYL HEALTH INC
Fractyl Health Inc is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity. The company focuses on transforming metabolic disease treatment from chronic symptomatic management to durable disease modifying therapies that target the organ level root causes of T2D and obesity.
About CFSB CFSB Bancorp Inc.
CFSB Bancorp Inc provides banking services. It offers a variety of financial services to individuals and small businesses through its offices in Quincy, Holbrook, and Weymouth. Its primary deposit products are savings, checking, and term certificate accounts, and its primary lending product is residential mortgage loans.The Company's loan portfolio includes residential real estate, commercial real estate, construction, and consumer loan segments. Residential real estate loans include classes for one- to four-family, multi-family, second mortgages and home equity lines of credit.